WhaleWatch
Sign inGet started
Smart Money Alert
Biocon Limited logo

Biocon Limited

New PositionBlock Deal
BIOCONPharmaceuticalsMarket Cap₹60K Cr
Value
₹30.00 Cr
Shares
7,50,000
Price
₹400
BNP Paribas
BNP Paribas
Foreign Investor
The move

BNP Paribas bought 7,50,000 shares of Biocon for ₹30.00 Cr at ₹400.00 apiece in a block deal.

About Biocon Limited
Visit stock

A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.

About BNP Paribas
Visit investor

French global bank with around EUR 2.6 trillion in assets. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.

Get the next move the moment it happens.
Follow BNP Paribas and Biocon Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Biocon Limited shareholdersBNP Paribas's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Biocon Limited
More moves in Biocon Limited
Kotak Mutual FundIncreased
Kotak Mutual Fund bought 12,77,000 shares of Biocon Limited for ₹49.16 Cr at ₹385.00 apiece in a block deal.
9 Sept 2026
Read more
Government Pension Fund Global (Norway)New position
Government Pension Fund Global (Norway) bought 6,500,02 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal on September 9, 2026.
9 Sept 2026
Read more
Edelweiss Mutual FundNew position
Edelweiss Mutual Fund bought 6,50,002 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.
9 Sept 2026
Read more
Societe GeneraleNew position
Societe Generale bought 6.5 lakh shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.
9 Sept 2026
Read more
Bajaj Allianz Life InsuranceNew position
Bajaj Allianz Life Insurance bought 6,500,022 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.
9 Sept 2026
Read more
See all moves
BNP Paribas
More moves by BNP Paribas
BSE Limited
Direction, size, price and stake change for this move, with what it means for the company.
29 Sept 2026. Sign in to see this move
Meesho LimitedNew position
BNP Paribas bought 20.5 lakh shares of Meesho Limited for ₹47.77 Cr at ₹233.00 apiece in a block deal.
MEESHO23 Sept 2026
Read more
Pine Labs LimitedNew position
BNP Paribas bought 39.3 lakh shares of Pine Labs Limited for ₹73.79 Cr at ₹187.75 apiece in a block deal.
PINELABS22 Sept 2026
Read more
Granules India LimitedNew position
BNP Paribas bought 13,18,051 shares of Granules India Limited for ₹115.00 Cr at ₹872.50 apiece in a block deal.
GRANULES11 Sept 2026
Read more
Biocon LimitedNew position
BNP Paribas bought 6,50,002 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.
BIOCON9 Sept 2026
Read more
See all moves